GSK to invest in venture fund for orphan drug discovery

06/20/2013 | Reuters

GlaxoSmithKline is investing $23.5 million in Kurma Biofund II, a venture capital fund that works with a network of research institutes in Europe and focuses on rare diseases. GSK invested earlier this year in Avalon Ventures to fund up to 10 drug discovery startup companies over the next three years.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC